Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets - Germany
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €45 | ― | 1.30% | Reiterated | ||||
 | Symrise | BUY €138 | ― | -0.70% | Reiterated | Symrise (0G6T) Receives a Buy from UBS | |||
 | BASF SE | BUY €53 | ― | -3.50% | Reiterated | ||||
 | Brenntag AG | BUY €76 | ― | -5.90% | Upgraded | Brenntag AG (0MPT) was upgraded to a Buy Rating at Berenberg Bank | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €100 | ― | 16.70% | Reiterated | ||||
 | Continental Aktiengesellschaft | BUY €80 | ― | -1.80% | Reiterated | UBS Sticks to Its Buy Rating for Continental Aktiengesellschaft (CTTAF) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €105 | ― | 4.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €86 | ― | 4.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €72 | ― | 4.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €35→€33 | ― | 33.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €130 | ― | 3.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €160 | ― | 2.50% | Reiterated | ||||
| CTS Eventim AG & Co. KGaA | BUY €107→€105 | ― | -8.50% | Reiterated | Hauck & Aufhaeuser Remains a Buy on CTS Eventim AG & Co. KGaA (0EEE) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €38→€35 | ― | 2.40% | Reiterated | ||||
| Redcare Pharmacy | HOLD €135→€140 | ― | -2.60% | Reiterated | Redcare Pharmacy NV (RDC:GR) PT Raised to EUR140 at Morgan StanleyMorgan Stanley raised its price target on Redcare Pharmacy NV (RDC:GR) to EUR140.00 (from EUR135.00) while maintaining a Equalweight rating. | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €116 | ― | 2.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €36 | ― | 4.10% | Reiterated | ||||
 | RTL Group SA | BUY €34 | ― | -2.70% | Assigned | Warburg Research Reaffirms Their Buy Rating on RTL Group SA (0MNC) | |||
| ProSiebenSat.1 Media SE | HOLD €6.5 | ― | -2.70% | Assigned | Warburg Research Sticks to Their Hold Rating for ProSiebenSat.1 Media SE (0QG9) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €41 | ― | 6.50% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €54 | ― | 3.40% | Reiterated | ||||
 | CEWE Stiftung & Co. KGaA | BUY €124→€126 | ― | -2.90% | Reiterated | Baader Bank Sticks to Its Buy Rating for CEWE Stiftung & Co. KGaA (0N8F) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €86 | ― | 1.40% | Reiterated | ||||
 | Instone Real Estate Group | BUY €13.5 | ― | -7.40% | Reiterated | Instone Real Estate Group: Strong Market Position and Mid-Term Optimism Justify Buy Rating | |||
K+S Aktiengesellschaft | SELL €10 | ― | -6.30% | Reiterated | UBS Sticks to Their Sell Rating for K+S Aktiengesellschaft (0Q2N) | ||||
| Bayer | HOLD €30→€22 | ― | -1.20% | Reiterated | UBS Reaffirms Their Hold Rating on Bayer (0P6S) | |||
 | Siemens Healthineers AG | BUY €60 | ― | -8.60% | Reiterated | Jefferies Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF) | |||
| Sixt SE | BUY €100→€110 | ― | -10.00% | Reiterated | Jefferies Remains a Buy on Sixt SE (0NW7) | |||
| verbio Vereinigte BioEnergie | BUY €27→€22 | ― | -10.00% | Reiterated | verbio Vereinigte BioEnergie (0NLY) Receives a Buy from Jefferies | |||
| SMA Solar Technology | HOLD €19→€14 | ― | -10.00% | Reiterated | Jefferies Sticks to Its Hold Rating for SMA Solar Technology (0NIF) | |||
| PVA TePla | HOLD €14.5→€12 | ― | -10.00% | Reiterated | Jefferies Remains a Hold on PVA TePla (0NL1) | |||
| CTS Eventim AG & Co. KGaA | BUY €100 | ― | -0.50% | Reiterated | CTS Eventim AG & Co. KGaA: Buy Rating Affirmed Amid Strong Sales Growth and Strategic Acquisitions | |||
| CTS Eventim AG & Co. KGaA | BUY €101 | ― | -2.20% | Reiterated | J.P. Morgan Remains a Buy on CTS Eventim AG & Co. KGaA (0EEE) | |||
| CTS Eventim AG & Co. KGaA | BUY €98 | ― | -2.90% | Reiterated | Baader Bank Keeps Their Buy Rating on CTS Eventim AG & Co. KGaA (0EEE) | |||
 | Fresenius Medical Care AG & Co. KGaA | HOLD €39→€41 | ― | -0.40% | Reiterated | Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR41 at BarclaysBarclays analyst Hassan Al-Wakeel raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR41.00 (from EUR39.00) while maintaining a Equalweight rating. | |||
| Fresenius SE & Co. KGaA | BUY €38→€40 | ― | -0.40% | Reiterated | Fresenius SE #x26; Co KGaA (FRE:GR) (FSNUY) PT Raised to EUR40 at BarclaysBarclays analyst Hassan Al-Wakeel raised the price target on Fresenius SE Co KGaA (FRE:GR) (OTC: FSNUY) to EUR40.00 (from EUR38.00) while maintaining a Overweight rating. | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €37.5→€38 | ― | 10.80% | Reiterated | ||||
| Siemens Healthineers AG | BUY €62.5 | ― | -0.40% | Reiterated | Barclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF) | |||
 | Medios AG | BUY €23→€18 | ― | -6.80% | Reiterated | Deutsche Bank Reaffirms Their Buy Rating on Medios AG (MEDOF) | |||
| freenet | BUY €33→€34 | ― | -1.50% | Reiterated | freenet (0MV2) Receives a Buy from Deutsche Bank | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €130 | ― | 7.80% | Reiterated | ||||
 | Formycon AG | BUY €90 | ― | -18.30% | Reiterated | Positive Outlook for Formycon AG: CHMP Approval and Strategic Market Positioning Reinforce Buy Rating | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €380→€400 | ― | 29.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €30.5→€21.4 | ― | 4.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €149→€150 | ― | 12.20% | Reiterated | ||||
RWE AG | HOLD €51→€33 | ― | -2.70% | Reiterated | RWE AG: Hold Rating Amid Power Price Challenges and Strategic Opportunities | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €106→€121 | ― | 8.80% | Reiterated | ||||
| Heidelberg Materials | HOLD €109→€119 | ― | -2.20% | Reiterated | Goldman Sachs Sticks to Their Hold Rating for Heidelberg Materials (0MG2) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €29→€27 | ― | 3.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €666 | ― | 12.70% | Reiterated |
Rows:
